Education
About Us
Working with TipRanks
Follow Us
Eastwood Bio-Medical Canada Inc (TSE:EBM)
:EBM
Total Valuation
Eastwood Bio-Medical Canada has a market cap or net worth of C$35.13M. The enterprise value is C$65.44M.
Market CapC$35.13M
Enterprise ValueC$65.44M
Share Statistics
Eastwood Bio-Medical Canada has 68,885,970 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding68,885,970
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Eastwood Bio-Medical Canada’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 22.86%.
Return on Equity (ROE)0.20
Return on Assets (ROA)-1.52
Return on Invested Capital (ROIC)22.86%
Return on Capital Employed (ROCE)0.22
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover3.57
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Eastwood Bio-Medical Canada is ―. Eastwood Bio-Medical Canada’s PEG ratio is 5.31.
PE Ratio―
PS Ratio61.66
PB Ratio-29.59
Price to Fair Value-29.59
Price to FCF2.50K
Price to Operating Cash Flow-3.87K
PEG Ratio5.31
Income Statement
In the last 12 months, Eastwood Bio-Medical Canada had revenue of 782.08K and earned -332.77K in profits. Earnings per share was >-0.01.
Revenue782.08K
Gross Profit506.03K
Operating Income-354.70K
Pretax Income-332.77K
Net Income-332.77K
EBITDA-309.73K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was 19.30K and capital expenditures 0.00, giving a free cash flow of 19.31K billion.
Operating Cash Flow19.30K
Free Cash Flow19.31K
Free Cash Flow per Share<0.01
Dividends & Yields
Eastwood Bio-Medical Canada pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.27
52-Week Price Change45.71%
50-Day Moving Average0.74
200-Day Moving Average0.60
Relative Strength Index (RSI)36.74
Average Volume (3m)3.49K
Important Dates
Eastwood Bio-Medical Canada upcoming earnings date is Mar 27, 2026, TBA (Confirmed).
Last Earnings DateMar 2, 2026
Next Earnings DateMar 27, 2026
Ex-Dividend Date―
Financial Position
Eastwood Bio-Medical Canada as a current ratio of 0.02, with Debt / Equity ratio of -7.37%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap<0.01
Net Debt to EBITDA-0.19
Interest Coverage Ratio-39.38
Taxes
In the past 12 months, Eastwood Bio-Medical Canada has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Eastwood Bio-Medical Canada EV to EBITDA ratio is -155.88, with an EV/FCF ratio of 2.50K.
EV to Sales61.73
EV to EBITDA-155.88
EV to Free Cash Flow2.50K
EV to Operating Cash Flow2.50K
Balance Sheet
Eastwood Bio-Medical Canada has C$17.70K in cash and marketable securities with C$78.01K in debt, giving a net cash position of -C$60.30K billion.
Cash & Marketable SecuritiesC$17.70K
Total DebtC$78.01K
Net Cash-C$60.30K
Net Cash Per Share>-C$0.01
Tangible Book Value Per Share-C$0.02
Margins
Gross margin is 63.18%, with operating margin of -45.35%, and net profit margin of -42.55%.
Gross Margin63.18%
Operating Margin-45.35%
Pretax Margin-42.55%
Net Profit Margin-42.55%
EBITDA Margin-39.60%
EBIT Margin-45.35%
Analyst Forecast
The average price target for Eastwood Bio-Medical Canada is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-9.02%
EPS Growth Forecast14.29%